IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 205 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $25,018,000 | -68.5% | 790,197 | -53.8% | 2.67% | -64.0% |
| Q4 2020 | $79,381,000 | +90.0% | 1,710,803 | +13.3% | 7.41% | +190.7% |
| Q4 2019 | $41,778,000 | +36.7% | 1,509,327 | -10.1% | 2.55% | -15.7% |
| Q3 2019 | $30,564,000 | -78.7% | 1,679,327 | -71.3% | 3.02% | -70.2% |
| Q2 2019 | $143,512,000 | +1223.8% | 5,852,836 | +413.4% | 10.16% | +1384.9% |
| Q1 2019 | $10,841,000 | -80.0% | 1,140,000 | -64.4% | 0.68% | -86.2% |
| Q1 2018 | $54,183,000 | +2814.6% | 3,206,073 | +1279.6% | 4.95% | +2847.0% |
| Q4 2017 | $1,859,000 | – | 232,396 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |